ArticlePLoS pathogens2019

RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.

Markus Lesch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.